Teva Parenteral Medicines, Inc.
10 drugs in NADAC|10 Generic,0 Brand
Teva Parenteral Medicines, Inc. lists 10 NDCs in the CMS NADAC file (10 generic, 0 brand), at an average NADAC of $2.84 per unit, with a week-over-week move of +1.9% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
10
10G / 0B
Avg Price / Unit
$2.8362
$0.53 – $7.39
Avg 7d Change
+1.88%
Across 4 drugs with changes
7d Activity
of 10 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Triamcinolone Acetonide market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Corticosteroid therapeutic class
Review the broader class where Teva Parenteral Medicines, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Teva Parenteral Medicines, Inc. make?
Teva Parenteral Medicines, Inc. lists 10 NDCs in the CMS NADAC file — 10 generic and 0 brand products.
What is the average price of Teva Parenteral Medicines, Inc. drugs?
The average NADAC across Teva Parenteral Medicines, Inc.'s portfolio is $2.8362 per unit, ranging from $0.5290 to $7.3915.
What types of drugs does Teva Parenteral Medicines, Inc. make?
Teva Parenteral Medicines, Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (3), Folate Analog Metabolic Inhibitor (3), Opioid Agonist (2), Platinum-based Drug (1), Dopamine-2 Receptor Antagonist (1).
Has Teva Parenteral Medicines, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Teva Parenteral Medicines, Inc. in the openFDA feed.
How has Teva Parenteral Medicines, Inc.'s pricing changed recently?
Over the past 7 days, 3 Teva Parenteral Medicines, Inc. products rose and 1 fell, with a portfolio-wide average change of +1.9%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRIAMCINOLONE ACET 40 MG/ML VL Triamcinolone Acetonide | $7.3915 per ML | +5.74% |
TRIAMCINOLONE ACET 200 MG/5 ML Triamcinolone Acetonide | $6.3832 per ML | +0.87% |
TRIAMCINOLONE ACET 400 MG/10 ML Triamcinolone Acetonide | $4.7820 per ML | -1.79% |
HYDROMORPHONE 10 MG/ML VIAL HYDROMORPHONE HYDROCHLORIDE | $2.5663 per ML | — |
HYDROMORPHONE 50 MG/5 ML VIAL HYDROMORPHONE HYDROCHLORIDE | $2.5663 per ML | — |
METHOTREXATE 50 MG/2 ML VIAL Methotrexate | $1.8033 per ML | +2.68% |
CARBOPLATIN 150 MG/15 ML VIAL Carboplatin | $0.9933 per ML | — |
METHOTREXATE 250 MG/10 ML VIAL Methotrexate | $0.7020 per ML | — |
METHOTREXATE 1 GRAM/40 ML VIAL Methotrexate | $0.6450 per ML | — |
METOCLOPRAMIDE 10 MG/2 ML VIAL Metoclopramide | $0.5290 per ML | — |